SCHEMBL5028174

SCHEMBL5028174

c1ccc(-c2cc(-n3c4ccccc4c4ccccc43)c3oc4ccc(-c5ccc6oc7c(-c8ccccc8)cc(-n8c9ccccc9c9ccccc98)cc7c6c5)cc4c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PRKDC P78527 3/20 0.34
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
PLA2G10 O15496 1/20 0.32
PGR P06401 1/20 0.32
ALOX5 P09917 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
BRCA1 P38398 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228705 0.91 PLA2G2A (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22181826 0.90 L3MBTL1 (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL18265975 0.90 PLA2G2A (0.36) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890118 0.90 KDM4E (0.36) KDM4EATML3MBTL1MEN1ALDH1A1
SCHEMBL22181822 0.90 L3MBTL1 (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL17166618 0.90 PRKDC (0.40) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890359 0.89 KDM4E (0.35) KDM4EATML3MBTL1MEN1ALDH1A1
SCHEMBL14867871 0.88 PLA2G2A (0.37) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL14648687 0.88 KDM4E (0.38) KDM4EATML3MBTL1PRKDCMEN1
SCHEMBL17166687 0.87 PRKDC (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130119360-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME MERCK PATENT GMBH (DE) 2013-05-16 US disclosed
US-8367224-B2 Organic electroluminescence element, new compound for the same, display device and lighting device using the same KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-05 US disclosed
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME AOC2, AOC3, CDYL PLA2G2A 2737/4885PLA2G4A 2855/4885KDM4E 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.